Related Experiment Video

Updated: May 19, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Heart failure and mechanical circulatory support

Stephen Andrew Esper1, Kathirvel Subramaniam

  • 1Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.

Best Practice & Research. Clinical Anaesthesiology
|August 23, 2012
PubMed

Insights

Cardiovascular disease (CVD) is a major global health concern, significantly impacting Europe and the USA. This review focuses on congestive heart failure (HF), exploring its epidemiology, pathophysiology, and therapeutic options for anesthesiologists.

Area of Science:

  • Cardiology and Anesthesiology
  • Public Health and Epidemiology

Background:

  • Cardiovascular disease (CVD) is a leading cause of morbidity and mortality globally, representing a significant disease burden in Europe and the USA.
  • Congestive heart failure (HF) is a prevalent condition requiring increased attention, particularly in perioperative and intensive care settings.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, and current therapies for congestive heart failure (HF).
  • To provide anesthesiologists with an understanding of HF management, including mechanical circulatory support and heart transplantation.

Main Methods:

  • Literature review of cardiovascular disease (CVD) and congestive heart failure (HF) epidemiology and pathophysiology.
  • Analysis of established and emerging therapies for end-stage HF, including mechanical circulatory assistance and heart transplantation.

Main Results:

  • Cardiovascular disease (CVD) affects millions worldwide, with heart failure (HF) being a major component.
  • Mechanical circulatory assistance and heart transplantation are key treatments for end-stage HF, with specific indications and contraindications.

Conclusions:

  • Anesthesiologists increasingly encounter patients with heart failure (HF), necessitating comprehensive knowledge of the condition and its management.
  • Understanding the efficacy, safety, and cost of circulatory support therapies is crucial for optimizing patient care in advanced HF.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...